martes, 2 de febrero de 2016

National Guideline Clearinghouse | Guidelines by Topic: Cardiovascular Diseases (7)

National Guideline Clearinghouse | Guidelines by Topic



National Guideline Clearinghouse (NGC)

Guidelines by Topic

Cardiovascular Diseases (393)

Guidelines by Topic

Cardiovascular Diseases (393)
121-140 of 393   < Previous Next >
 
121. 
Screening for sudden cardiac death before participation in high school and collegiate sports. 2013 Jul. NGC:010130
American College of Preventive Medicine - Medical Specialty Society. View all guidelines by the developer(s)
122. 
Varicose veins in the legs. The diagnosis and management of varicose veins. 2013 Jul. NGC:009975
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
123. 
Aortic valve and ascending aorta guidelines for management and quality measures. 2013 Jun. NGC:010036
Society of Thoracic Surgeons - Medical Specialty Society. View all guidelines by the developer(s)
124. 
125. 
Rivaroxaban for treating pulmonary embolism and preventing recurrent venous thromboembolism. 2013 Jun. NGC:009949
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
126. 
Stroke rehabilitation. Long-term rehabilitation after stroke. 2013 Jun. NGC:009955
National Clinical Guideline Centre - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
128. 
Venous thromboembolism prophylaxis and treatment in patients with cancer: American Society of Clinical Oncology clinical practice guideline update. 2007 Dec (revised 2013 Jun; reaffirmed 2015 Feb). NGC:009844
American Society of Clinical Oncology - Medical Specialty Society. View all guidelines by the developer(s)
129. 
Feverish illness in children: assessment and initial management in children younger than 5 years. 2007 May (revised 2013 May). NGC:009891
National Collaborating Centre for Women's and Children's Health - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
130. 
Healthy lifestyles. 2008 Mar (revised 2013 May). NGC:009897
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
131. 
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion. 2013 May. NGC:009895
National Institute for Health and Care Excellence (NICE) - National Government Agency [Non-U.S.]. View all guidelines by the developer(s)
132. 
Stable coronary artery disease. 1994 Jul (revised 2013 May). NGC:009899
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
133. 
134. 
Bortezomib in multiple myeloma and lymphoma. 2006 Apr 3 (revised 2013 Mar 18). NGC:010003
Program in Evidence-based Care - State/Local Government Agency [Non-U.S.]. View all guidelines by thedeveloper(s)
135. 
Assessment and management of foot ulcers for people with diabetes. 2005 Mar (revised 2013 Mar). NGC:010101
Registered Nurses' Association of Ontario - Professional Association. View all guidelines by the developer(s)
136. 
Deep venous thrombosis and thromboembolism in patients with cervical spinal cord injuries. In: Guidelines for the management of acute cervical spine and spinal cord injuries. 2013 Mar. NGC:009771
American Association of Neurological Surgeons - Medical Specialty Society; Congress of Neurological Surgeons - Professional Association. View all guidelines by the developer(s)
137. 
Management of vertebral artery injuries following non-penetrating cervical trauma. In: Guidelines for the management of acute cervical spine and spinal cord injuries. 2013 Mar. NGC:009770
American Association of Neurological Surgeons - Medical Specialty Society; Congress of Neurological Surgeons - Professional Association. View all guidelines by the developer(s)
138. 
Proton beam radiation therapy. 2013 Mar. NGC:009838
CancerControl Alberta - State/Local Government Agency [Non-U.S.]. View all guidelines by the developer(s)
139. 
Recommendations for antithrombotic agents for the prevention of stroke and systemic embolism in patients with atrial fibrillation. 2012 Jun (revised 2013 Mar). NGC:009802
Canadian Agency for Drugs and Technologies in Health - Nonprofit Organization. View all guidelines by thedeveloper(s)
140. 
Antithrombotic therapy supplement. 2001 Sep (revised 2013 Feb). NGC:009698
Institute for Clinical Systems Improvement - Nonprofit Organization. View all guidelines by the developer(s)
121-140 of 393   < Previous Next >

No hay comentarios:

Publicar un comentario